Intellectual Property Law and Copyright Laws

Two recent trade secret lawsuits against OpenAI reveal the critical difference between viable and dismissible claims under the Defend Trade Secrets Act. While xAI's case was dismissed and now faces a million-dollar fee demand, Apple's complaint demonstrates how to properly plead active acquisition, documented knowledge, and directed exfiltration in talent-raiding disputes.

When a multi-million-dollar jury verdict gets slashed to single digits by a trial judge, it usually marks a devastating end to a company’s legal battle.

On July 10, Apple filed a complaint in the U.S. District Court for the Northern District of California asserting claims under the federal Defend Trade Secrets Act of 2016 (DTSA) against OpenAI, its hardware affiliate...

It is one of the most jarring moments in any M&A transaction: a buyer’s attorney asks to see IP assignment agreements for the core technology or brand assets, and the seller’s attorney realizes those agreements...

When a demand letter alleging copyright or trademark infringement arrives, businesses face critical decisions about how to respond. Patent attorney David Nocilly discusses strategies for assessing claim legitimacy, navigating music and image licensing complexities, and implementing proactive measures to reduce intellectual property risk through proper documentation and licensing practices.

Understanding the fundamental differences between patents, trademarks, and copyrights is crucial for anyone looking to protect their intellectual property. This comprehensive guide explores how each form of protection works, when to use them, and debunks common misconceptions that could leave your creative works, inventions, or brand vulnerable.

In Intellectual Pixels Limited v. Sony Interactive Entertainment LLC, the Federal Circuit affirmed a Patent Trial and Appeal Board decision holding claims 1-12 of U.S. Patent No. 10,681,109 unpatentable as obvious.

When Enanta Pharmaceuticals filed its provisional patent application before Pfizer disclosed nirmatrelvir, it appeared to have secured priority. However, a single character error—a "2" instead of "1" in a chemical formula—meant the provisional never actually described the compound at issue. The Federal Circuit's decision in this $19 billion case reveals how a seemingly minor drafting mistake can invalidate an entire patent portfolio, even when you file first.

The United States Patent and Trademark Office has fundamentally altered how patent applicants receive physical copies of granted patents, shifting from an automatic delivery system to an opt-in model effective March 9, 2026. Patent counsel and portfolio managers must now proactively request ceremonial paper copies when paying issue fees, or clients will receive only the official electronic grant. This procedural change carries significant implications for law firms and corporate patent departments that valu

When a multi-million-dollar jury verdict gets slashed to single digits by a trial judge, it usually marks a devastating end to a company’s legal battle.

When a demand letter alleging copyright or trademark infringement arrives, businesses face critical decisions about how to respond. Patent attorney David Nocilly discusses strategies for assessing claim legitimacy, navigating music and image licensing complexities, and implementing proactive measures to reduce intellectual property risk through proper documentation and licensing practices.

When Zaha Hadid Architects rebranded as ZHA following a protracted legal battle with the Zaha Hadid Foundation over trademark licensing fees, it raised fundamental questions about founder succession planning in professional services firms. This article examines whether the choice between perpetual royalties and complete separation was truly the only path, proposing an innovative Equity-for-Legacy Model that could have preserved both commercial sustainability and cultural legacy through aligned ownership rat